Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|5|539-549

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.5, 2015-04, pp. : 539-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The combined serum levels of miR‐375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1406-1416

John Wiley & Sons Inc

Access to resources Recommend Favorite

Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 397-402

Karger

Access to resources Recommend Favorite

The post PSA era: new developments in biomarkers, imaging and biopsy techniques in prostate cancer detection

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 6, Iss. 4, 2015-07 ,pp. : 25-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 10, 2010-10 ,pp. : 1674-1680

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biparametric MRI for prostate cancer detection

By  

BJU INTERNATIONAL, Vol. 115, Iss. 3, 2015-03 ,pp. : 381-388

John Wiley & Sons Inc

Access to resources Recommend Favorite